In the BioHarmony Drug Report Database

"Preview" Icon

Bleomycin

Blenoxane (bleomycin) is a small molecule pharmaceutical. Bleomycin was first approved as Blenoxane on 1982-01-01. It is used to treat choriocarcinoma, hodgkin disease, melanoma, non-hodgkin lymphoma, and sarcoma amongst others in the USA.

 

Trade Name

 

Blenoxane
 

Common Name

 

bleomycin
 

ChEMBL ID

 

CHEMBL403664
 

Indication

 

choriocarcinoma, hodgkin disease, melanoma, non-hodgkin lymphoma, sarcoma, squamous cell carcinoma, teratocarcinoma, testicular neoplasms
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Bleomycin structure rendering